"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This trial is a 6-week, double-blind, placebo-controlled, randomized-withdrawal, multicenter
study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult
subjects with OSA.